SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc. announced today that Roberto Pedro Rosenkranz, Ph.D., and James A. Schoeneck have been appointed to the FibroGen Board of Directors. FibroGen has expanded the Board to include Dr. Rosenkranz and Mr. Schoeneck, who will not replace current Directors.
